Oppenheimer analyst Leland Gershell maintained a Buy rating on Protara Therapeutics (TARA) today and set a price target of $32.00.
The post Protara Therapeutics (TARA) Gets a Buy Rating from Oppenheimer appeared first on Smarter Analyst.
Oppenheimer analyst Leland Gershell maintained a Buy rating on...

https://www.smarteranalyst.com/new-blurbs/protara-therapeutics-tara-gets-a-buy-rating-from-oppenheimer/

#SmarterAnalyst